Behind the Mystery: Why We Started the Series
February 29, 2020
Behind the Mystery co-creators Molly Mager and Carri Levy talk about what prompted them to start the series. Molly’s twin brother was diagnosed with acinar cell cystadenoma at the age of 25, while Carri’s daughter Ilana Jacqueline suffered for years before being diagnosed with Primary Immune Deficiency Disease.
We are excited to celebrate #RareDiseaseDay this February 29th, 2020. For this, we’ll be sharing our favorite patient stories to help raise awareness and give a voice to those who need one. Join us on this day!
A specialized, recurring segment on The Balancing Act, Behind the Mystery is devoted to rare and genetic diseases. It highlights the emotional, scientific, and medical aspects associated with rare and genetic diseases. Its goal is to expand awareness for rare and genetic diseases through partnerships with pharmaceutical and biotech companies, while giving voices to the patients, families, and advocates affected via our national television platform airing on Lifetime. https://thebalancingact.com/category/… www.linkedin.com/company/behind-the-mystery
Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]
iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.
There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.